pembrolizumab
merck
['keynote-412', 'pembro']
#esmo22 presidential symposium ii highlights: keynote-412 (lba5; jean-michel machiels)
-no significant efs benefit with pembro+crt vs placebo+crt for la #hnscc (n=804)
-pd-l1 expression may predict benefit 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge